[HTML][HTML] COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Initial studies found increased severity of coronavirus disease 2019 (COVID-19), caused by
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in patients …
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in patients …
[HTML][HTML] COVID-19 and preexisting comorbidities: risks, synergies, and clinical outcomes
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated
symptoms, named coronavirus disease 2019 (COVID-19), have rapidly spread worldwide …
symptoms, named coronavirus disease 2019 (COVID-19), have rapidly spread worldwide …
[HTML][HTML] Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions
JX Li, CL Cummins - Nature Reviews Endocrinology, 2022 - nature.com
Glucocorticoid hormones were discovered to have use as potent anti-inflammatory and
immunosuppressive therapeutics in the 1940s and their continued use and development …
immunosuppressive therapeutics in the 1940s and their continued use and development …
Diabetes and COVID-19: The past, the present, and the future
Diabetes, one of the most prevalent chronic diseases in the world, is strongly associated
with a poor prognosis in COVID-19. Scrupulous blood sugar management is crucial, since …
with a poor prognosis in COVID-19. Scrupulous blood sugar management is crucial, since …
COVID-19 and diabetes: a collision and collusion of two diseases
The coronavirus disease 2019 (COVID-19) pandemic has infected> 22.7 million and led to
the deaths of 795,000 people worldwide. Patients with diabetes are highly susceptible to …
the deaths of 795,000 people worldwide. Patients with diabetes are highly susceptible to …
[HTML][HTML] Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study
V Lampasona, M Secchi, M Scavini, E Bazzigaluppi… - Diabetologia, 2020 - Springer
Aims/hypothesis The aim of the study was to characterise the humoral response against
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with diabetes …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with diabetes …
[HTML][HTML] Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing
Coronavirus Disease 2019 (COVID-19), caused by a new strain of coronavirus called
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), was declared a …
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), was declared a …
[HTML][HTML] Current understanding in the pathophysiology of SARS-CoV-2-associated rhino-orbito-cerebral mucormycosis: a comprehensive review
A Jose, S Singh, A Roychoudhury, Y Kholakiya… - Journal of maxillofacial …, 2021 - Springer
Aim Recently, with the second wave of COVID-19, the Indian subcontinent has witnessed a
dramatic rise in mucormycosis infection in patients recovered from COVID-19. This …
dramatic rise in mucormycosis infection in patients recovered from COVID-19. This …
Post-COVID syndrome, inflammation, and diabetes
AA Rizvi, A Kathuria, W Al Mahmeed… - Journal of Diabetes and …, 2022 - Elsevier
The raging COVID-19 pandemic is in its third year of global impact. The SARS CoV 2 virus
has a high rate of spread, protean manifestations, and a high morbidity and mortality in …
has a high rate of spread, protean manifestations, and a high morbidity and mortality in …
[HTML][HTML] Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral–bacterial interactions
IL Kruglikov, M Shah, PE Scherer - Elife, 2020 - elifesciences.org
Obesity and diabetes are established comorbidities for COVID-19. Adipose tissue
demonstrates high expression of ACE2 which SARS-CoV-2 exploits to enter host cells. This …
demonstrates high expression of ACE2 which SARS-CoV-2 exploits to enter host cells. This …